Stammdaten
Unternehmen
| Name | VERACYTE, INC. |
|---|---|
| Ticker | VCYT |
| CIK | 0001384101 |
Branche
| SIC-Code | 8071 |
|---|---|
| Beschreibung | Services-Medical Laboratories |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | VERACYTE, INC. |
Status
| Zuletzt geprüft | 2026-03-20 22:23:51.182033 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 517,145,000 | 66,353,000 | 0.82 | 1,406,019,000 | 1,309,576,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -13,941 | 36.33 | -506,459.80 | -192,4% | |
| 2026-03-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -1,664 | 36.34 | -60,468.60 | -23,0% | |
| 2026-03-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -4,994 | 35.29 | -176,256.24 | -67,0% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4,400 | 35.55 | -156,409.44 | -59,4% | |
| 2026-03-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -26,279 | 36.28 | -953,367.96 | -362,1% | |
| 2026-03-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -5,260 | 35.19 | -185,082.57 | -70,3% | |
| 2026-03-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -19,244 | 35.56 | -684,226.19 | -259,9% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -13,941 | 36.33 | -506,459.80 | -192,4% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4,400 | 35.55 | -156,409.44 | -59,4% | |
| 2026-03-02 | Febbo Phillip G. | Officer, Chief Scientific & Med Officer | Open Market Sale | -13,425 | 36.16 | -485,429.21 | -184,4% | |
| 2025-12-16 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -10,639 | 43.13 | -458,835.60 | -174,3% | |
| 2025-12-16 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -100 | 43.68 | -4,368.00 | -1,7% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -12,808 | 45.84 | -587,080.30 | -223,0% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -800 | 46.59 | -37,271.84 | -14,2% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -6,392 | 44.52 | -284,571.20 | -108,1% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -800 | 46.59 | -37,271.84 | -14,2% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -12,808 | 45.84 | -587,080.30 | -223,0% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -6,392 | 44.52 | -284,571.20 | -108,1% | |
| 2025-12-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -3,220 | 47.35 | -152,462.17 | -57,9% | |
| 2025-12-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -1,278 | 47.51 | -60,717.78 | -23,1% | |
| 2025-12-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -702 | 47.51 | -33,352.02 | -12,7% | |
| 2025-12-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -720 | 47.10 | -33,908.76 | -12,9% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -8,537 | 46.61 | -397,946.28 | -151,2% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4,741 | 47.25 | -224,008.93 | -85,1% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -8,537 | 46.61 | -397,946.28 | -151,2% | |
| 2025-12-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -4,448 | 46.90 | -208,613.42 | -79,2% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4,741 | 47.25 | -224,008.93 | -85,1% | |
| 2025-11-25 | JONES EVAN/ FA | Director | Open Market Sale | -1,106 | 50.25 | -55,575.73 | -21,1% | |
| 2025-11-25 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2,808 | 50.00 | -140,400.00 | -53,3% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -1,491 | 40.95 | -61,060.33 | -23,2% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -7,049 | 42.48 | -299,416.85 | -113,7% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -1,460 | 43.21 | -63,085.87 | -24,0% | |
| 2025-11-10 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -5,102 | 42.33 | -215,978.37 | -82,0% | |
| 2025-11-07 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -5,818 | 40.21 | -233,928.98 | -88,9% | |
| 2025-11-05 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -7,000 | 41.00 | -287,000.00 | -109,0% | |
| 2025-11-05 | EASTHAM KARIN | Director | Open Market Sale | -9,674 | 40.02 | -387,191.21 | -147,1% | |
| 2025-11-05 | EASTHAM KARIN | Director | Open Market Sale | -9,674 | 40.02 | -387,191.21 | -147,1% | |
| 2025-11-05 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -6,466 | 40.00 | -258,640.00 | -98,2% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -408 | 41.74 | -17,031.18 | -6,5% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -1,126 | 43.03 | -48,455.05 | -18,4% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -10,837 | 43.80 | -474,701.78 | -180,3% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -5,872 | 45.07 | -264,640.47 | -100,5% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -24,296 | 45.73 | -1,110,990.48 | -422,0% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -657 | 46.38 | -30,468.77 | -11,6% | |
| 2025-11-05 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -7,000 | 41.00 | -287,000.00 | -109,0% | |
| 2025-10-06 | Febbo Phillip G. | Officer, Chief Scientific & Med Officer | Open Market Sale | -8,349 | 36.02 | -300,709.27 | -114,2% | |
| 2025-10-01 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2,539 | 35.00 | -88,865.00 | -33,8% | |
| 2025-10-01 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -2,160 | 35.00 | -75,607.56 | -28,7% | |
| 2025-10-01 | EPSTEIN ROBERT S | Director | Open Market Sale | -21,473 | 35.08 | -753,204.13 | -286,1% | |
| 2025-09-19 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -2,283 | 33.69 | -76,919.52 | -29,2% | |
| 2025-09-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -7,667 | 30.41 | -233,132.77 | -88,6% | |
| 2025-06-13 | Bhanji Muna | Director | Open Market Sale | -4,589 | 26.67 | -122,366.60 | -46,5% | |
| 2025-06-13 | EASTHAM KARIN | Director | Open Market Sale | -4,590 | 26.66 | -122,387.76 | -46,5% | |
| 2025-06-13 | EASTHAM KARIN | Director | Open Market Sale | -4,590 | 26.66 | -122,387.76 | -46,5% | |
| 2025-06-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2,809 | 27.20 | -76,409.86 | -29,0% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.